Back to PFE Stock Lookup
Pages: 1 2 »» Last Page

Pfizer (PFE) – Press Releases

Jun 25, 2015 11:20 AM Joseph J. Echevarria Elected To Pfizer’s Board Of Directors
Jun 25, 2015 11:15 AM Pfizer Declares 28-Cent Third-Quarter 2015 Dividend
Jun 24, 2015 01:19 PM CDC Advisory Committee on Immunization Practices Votes to Recommend Serogroup B Meningococcal Disease Vaccination including TRUMENBA® for Adolescents and Young Adults 16 through 23 Years of Age
Jun 23, 2015 02:15 PM GlycoMimetics to Receive $20 Million Payment from Pfizer Following Initiation of Phase 3 Trial with Rivipansel
Jun 23, 2015 02:00 PM Pfizer Announces Enrollment Of First Patient In Phase 3 Trial In Sickle Cell Disease
Jun 23, 2015 10:00 AM Pfizer Invites Public To View And Listen To Webcast Of July 28 Conference Call With Analysts
Jun 23, 2015 08:00 AM New Online Community, Quitter’s Circle, Helps Smokers Trade Cigarettes for Real-Time Support
Jun 22, 2015 08:45 AM Portola, Bristol-Myers Squibb and Pfizer Announce Full Results of Second Part of Phase 3 ANNEXA-A(TM) Study Demonstrating That Investigational Andexanet Alfa Sustained Reversal of Anticoagulant Effect
Jun 22, 2015 08:45 AM Portola, Bristol-Myers Squibb and Pfizer Announce Full Results of Second Part of Phase 3 ANNEXA-A(TM) Study Demonstrating That Investigational Andexanet Alfa Sustained Reversal of Anticoagulant Effect
Jun 22, 2015 07:00 AM Pfizer Enters Into Agreement To Acquire Nimenrix And Mencevax From GlaxoSmithKline
Jun 15, 2015 08:00 AM Pfizer Consumer Healthcare To Expand Caltrate And Centrum Production In China
Jun 11, 2015 03:00 PM Pfizer Reports Top Line Results from a Phase 3 Study Evaluating Desvenlafaxine Succinate Sustained-Release Formulation in Pediatric Patients with Major Depressive Disorder
Jun 10, 2015 08:00 AM Pfizer Builds Upon Robust Body Of Knowledge For XELJANZ® (tofacitinib citrate) With Clinical Trial And Real-World Use Data At The European League Against Rheumatism Annual Congress (EULAR 2015)
Jun 8, 2015 11:00 AM Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib for Chronic Plaque Psoriasis and Atopic Dermatitis at World Congress of Dermatology
Jun 4, 2015 09:00 AM Get Ready. Get Set. Get Old. Pfizer Challenges Conventional Views of Aging through New Campaign
May 30, 2015 07:30 AM Pfizer Announces Palbociclib More Than Doubled Progression-Free Survival in Phase 3 Trial for Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy
May 29, 2015 08:30 AM Pfizer’s RAPAMUNE® (sirolimus) Becomes First FDA-Approved Treatment for Lymphangioleiomyomatosis (LAM), A Rare Progressive Lung Disease
May 28, 2015 08:30 AM Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer
May 28, 2015 08:00 AM Pfizer Global Survey Finds Adults with Rheumatoid Arthritis Who Feel Comfortable Speaking Up About Their Concerns Have a More Positive View of Their Health
May 26, 2015 09:00 AM ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV
May 19, 2015 10:00 AM Pfizer Invites Public to View and Listen to Webcast of June 2 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations
May 14, 2015 12:27 PM Pfizer Receives Request For Additional Information From FTC Regarding Proposed Acquisition Of Hospira
May 14, 2015 08:07 AM Marc Tessier-Lavigne, Ph.D. to Leave Pfizer Board of Directors
May 13, 2015 05:01 PM Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody
May 11, 2015 04:30 PM Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company
May 6, 2015 12:48 PM Pfizer Appoints New Leaders for BioTherapeutics Research & Development and Rinat
May 6, 2015 08:00 AM Nodality Launches PathPro™ T Cell Receptor (TCR) and B Cell Receptor (BCR) Panels for Assessing Drug Impact on Functional Signaling in Primary Human Cells
May 6, 2015 04:51 AM ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy
Apr 28, 2015 07:30 AM Hospira Reports First-Quarter 2015 Results
Apr 28, 2015 07:00 AM PFIZER REPORTS FIRST-QUARTER 2015 RESULTS
Apr 27, 2015 09:00 AM China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer
Apr 23, 2015 02:07 PM Pfizer Hosts Annual Meeting Of Shareholders
Apr 21, 2015 10:00 AM Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer
Apr 21, 2015 08:00 AM Nodality Publishes Study Results Confirming the Company’s Diagnostic Can Predict Induction Therapy Response in Elderly Patients with Acute Myeloid Leukemia
Apr 21, 2015 08:00 AM Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Apr 20, 2015 08:00 AM Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer
Apr 16, 2015 02:26 PM Pfizer Invites Public to Listen to Webcast of April 23 Annual Meeting of Shareholders
Apr 16, 2015 08:30 AM Pfizer Launches 2014 Integrated Annual Review
Apr 15, 2015 08:00 AM Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine The
Apr 9, 2015 08:00 AM Pfizer Launches First Annual PCSK9 Competitive Grants Program to Advance Cardiovascular Disease Research
Apr 7, 2015 08:00 AM Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Finalize Agreement to Co-Promote XALKORI® (crizotinib)
Apr 7, 2015 07:00 AM GlycoMimetics Provides Update on Pfizer’s Plans to Initiate Phase 3 Trial with Rivipansel in Mid-2015
Apr 6, 2015 01:00 PM Kathrin U. Jansen, Ph.D., to Lead Pfizer’s Vaccine Research and Development Unit
Apr 2, 2015 02:30 PM Nodality Launches PathPro™ Chronic Lymphocytic Leukemia (CLL) Panels Based on Leading Single Cell Network Profiling (SCNPTM) Platform to Enhance Pharmaceutical R&D
Mar 30, 2015 11:00 AM Dr. Charles Reay Mackay To Join Pfizer as Chief Scientific Officer, Inflammation and Immunology Research Unit
Mar 26, 2015 10:00 AM Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
Mar 24, 2015 10:00 AM Pfizer Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts
Mar 23, 2015 08:00 AM Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab
Mar 20, 2015 01:00 PM Pfizer Announces Oral Tofacitinib Meets Primary Endpoints In Pivotal Phase 3 Psoriasis Trials
Mar 18, 2015 05:04 PM Results of Pfizer’s Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Published in the New England Journal of Medicine
Pages: 1 2 »» Last Page

Back to PFE Stock Lookup